| 000 | 01125 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516134637.0 | ||
| 264 | 0 | _c20130923 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1096-1208 | ||
| 024 | 7 |
_a10.1016/j.micpath.2013.02.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCaesar, Nicole M | |
| 245 | 0 | 0 |
_aNeisseria meningitidis serogroup B vaccine development. _h[electronic resource] |
| 260 |
_bMicrobial pathogenesis _cApr 2013 |
||
| 300 |
_a33-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntigens, Bacterial _ximmunology |
| 650 | 0 | 4 |
_aBacterial Outer Membrane Proteins _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMeningitis, Meningococcal _xprevention & control |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _ximmunology |
| 650 | 0 | 4 |
_aNeisseria meningitidis _xclassification |
| 650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup B _ximmunology |
| 700 | 1 | _aMyers, Kenneth A | |
| 700 | 1 | _aFan, Xin | |
| 773 | 0 |
_tMicrobial pathogenesis _gvol. 57 _gp. 33-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.micpath.2013.02.003 _zAvailable from publisher's website |
| 999 |
_c22510907 _d22510907 |
||